NVDA
NVIDIA Corporation
NVDA has the edge over VYX overall, supported by stronger fundamentals and stronger valuation.
VYX
NCR Voyix Corporation
VYX trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
VYX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Under pressure |
VYX's profitability is currently healthy, but its revenue, cash flow and balance sheet are under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over VYX in the historical PE scenario, which offers more potential upside but is not a forecast.
VYX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2x | $1.45 | -85% |
| Forward | 9.5x | $9.96 | — |
| Current | 14x | $9.96 | — |
| Fair | 22x | $15.83 | +59% |
| Expensive | 68x | $49.30 | +395% |
Historical ranges are pointers, not guarantees.
VYX's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its cheap range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
VYX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect VYX's earnings to grow and its profitability to improve, but its revenue to decline.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over VYX on earnings, with more consistent year-over-year improvement.
VYX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.05 | +45% |
| Q3 2026 | $0.72 | +$1.16 |
| Q2 2026 | $0.41 | -94% |
| Q1 2026 | $0.39 | -94% |
| Q4 2025 | $0.30 | -95% |
| Q3 2025 | -$0.44 | -110% |
| Q2 2025 | $7.13 | +$11.16 |
| Q1 2025 | $6.63 | +$10.02 |
| Q4 2024 | $6.47 | +$9.51 |
VYX has returned to profit: it earned $0.72 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over VYX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over VYX on profitability, with a higher operating margin.
VYX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $539M | -21% |
| Q2 2026 | $523M | -21% |
| Q1 2026 | $606M | -1.8% |
| Q4 2025 | $720M | +5.6% |
| Q3 2025 | $684M | -3.8% |
| Q2 2025 | $666M | -24% |
| Q1 2025 | $617M | -28% |
| Q4 2024 | $682M | -29% |
VYX's revenue has slid since its 2021 peak: $539M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +5.6 points |
| Q2 2026 | 2.7% | +0.6 points |
| Q1 2026 | -3.1% | +0.1 points |
| Q4 2025 | 2.4% | +2.1 points |
| Q3 2025 | 2.2% | +0.1 points |
| Q2 2025 | 2.1% | +2.6 points |
| Q1 2025 | -3.2% | -3.7 points |
| Q4 2024 | 0.3% | +14 points |
VYX's operating margin was 7.8% last quarter, up 5.6 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over VYX on cash generation, producing positive trailing cash flow while its opponent burns cash.
VYX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20M | -300% |
| Q2 2026 | -$24M | +$225M |
| Q1 2026 | $6M | +$56M |
| Q4 2025 | -$86M | +$91M |
| Q3 2025 | $10M | +11% |
| Q2 2025 | -$249M | -608% |
| Q1 2025 | -$50M | -$7M |
| Q4 2024 | -$177M | -$125M |
VYX has burned cash in six of the last eight quarters: −$124M over the past year, against −$466M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over VYX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
VYX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +2M shares |
| 1 year | +1.2% | +1.6M shares |
| 3 years | -0.8% | -1.1M shares |
| 5 years | +1.5% | +2M shares |
| Available history | -3.7% | -5.4M shares |
VYX has 140M diluted shares, up 1.2% from a year ago, despite $33M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8M |
| Q2 2026 | $11M |
| Q1 2026 | $9M |
| Q4 2025 | $5M |
| Q3 2025 | — |
| Q2 2025 | $7M |
| Q1 2025 | $62M |
| Q4 2021 | — |
VYX spent $33M buying back its own shares over the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over VYX on leverage, with a lower net debt burden relative to earnings.
VYX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.1x | Elevated |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 2.0x | Healthy |
| Q4 2024 | 1.2x | Healthy |
VYX's net debt is about 3.0 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
VYX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.3 | Neutral |
| Stochastic | 69.5 | Neutral |
VYX's weekly RSI is 62 (neutral) and its Stochastic is 70 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
VYX PE vs Technology Sector
| Metric | VYX | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 50% below |
| PE % | 35 | 35 | Same percentile |
VYX has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
VYX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.14 | 22% above |
| 20 week MA | $8.18 | 22% above |
| 50 week MA | $8.25 | 21% above |
| 100 week MA | $9.98 | 0.2% below |
| 200 week MA | $12.3 | 19% below |
VYX has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
VYX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.5 | $22.4 | +4.4% |
| 2021 | $22.4 | $24.1 | +7.5% |
| 2022 | $24.1 | $14.2 | -41% |
| 2023 | $14.2 | $16.9 | +19% |
| 2024 | $16.9 | $13.9 | -18% |
| 2025 | $13.9 | $10.5 | -24% |
| 2026 YTD | $10.5 | $9.96 | -5.5% |
VYX has the edge over NVDA on returns for 2026, with the stronger performance.